Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004104
Status:
COMPLETED
Last Update Posted:
2016-03-31
First Post:
1999-12-10
Brief Title:
Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma
Sponsor:
NYU Langone Health
Organization:
NYU Langone Health
Organization Data
Organization:
NYU Langone Health
Class:
OTHER
Study ID:
CDR0000067323
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NYU Langone Health
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |